2Ziyadeh FN,Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev, 2008,4 ( 1 ) : 39-45.
3Marshall SM. The podocyte:a potential therapeutic target in diabetic nephropathy? Curr Pharm Des,2007,13(26) :2713 - 2720.
4Koop K,Eikmans M,BacMe HJ,et al. Expression of Podocyte assodated molecules in acquired human kidney diseases. J Am Soc Nephrol,2003,14(8):2063-2071.
5Utimura R, Rjthaca Fujihara CK, Mattar AL, et al. Mycophenolate mofetil prevents the development of glomeruloar injury in experimental diabetes.Kidney Int,2003,63( 1 ) :209 -216.
3Yuan H,Takeuchi E,Taylor GA,et al.Nephrin dissociatesfrom actin,and its expression is reduced in early experimental membranous nephropathy.J Am Soc Nephrol,2002,13:946-956.
4Luimula P,Ahola H,Wang SX,et al.Nephrin in experimen-tal glomerular disease.Kidney Int,2000,58(4):1461-1468.
5Koop K,Eikmans M,Baelde HJ,et al.Expression of podocy-te-associated molecules in acquired human kidney diseases.J Am Soc Nephrol,2003,14:2063-2071.
6Mathieson PW.What has immune system got against the glomerular podocyte?Clin Exp Immunol,2003,134(1):1-5
7Pavenstadt H,Kriz W,Kretzler M.Cell biology of the glomerular podocyte.Physiol Rev,2003,83(1):253-307.
8Doublier S,Ruotsalainen V,Salvidio G,et al.Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome.Am J Pathol,2001,158(5):1723-1731.
9Wang SX,Rastaldi MP,Patari A,et al.Patterns of nephrin and a new proteinuria-associated protein expression in human renal diseases.Kidney Int,2002,61(1):141-147.
